Literature DB >> 6404830

In vitro response of human T cells to Pseudomonas aeruginosa.

J M Porwoll, H M Gebel, G E Rodey, R B Markham.   

Abstract

Pseudomonas aeruginosa is a gram-negative bacillus that is a major cause of morbidity and mortality in immunosuppressed patients, burn patients, and patients with cystic fibrosis. Although immunity to these bacteria has been associated with serum antibody, more recent evidence suggests that T-cell-mediated immunity may also be important. To evaluate human T-cell responsiveness to these bacteria, the optimal conditions were determined for in vitro proliferation of human peripheral blood lymphocytes and T-lymphocytes to Fisher-Devlin immunotype 1 P. aeruginosa. The proliferative response of normal adult peripheral blood lymphocytes to heat-killed P. aeruginosa was studied in 34 subjects (range, 7,600 to 111,500 net cpm). Analysis of cell subpopulations indicated that T-lymphocytes are the major proliferating cells and that this response is enhanced by the presence of adherent cells. Data from fetal cord lymphocyte responses suggest that the proliferation seen in normal adult lymphocytes is induced by antigenic and not mitogenic stimulation.

Entities:  

Mesh:

Year:  1983        PMID: 6404830      PMCID: PMC264907          DOI: 10.1128/iai.40.2.670-674.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Contribution of serum and cellular factors in host defense reactions. I. Serumfactors in host resistanc.

Authors:  K F AUSTEN; Z A COHN
Journal:  N Engl J Med       Date:  1963-04-25       Impact factor: 91.245

2.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Pulmonary host defenses in rabbits after immunization with Pseudomonas antigens: the interaction of bacteria, antibodies, macrophages, and lymphocytes.

Authors:  H Y Reynolds
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

4.  Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.

Authors:  E Diaz; L L Mosovich; E Neter
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

5.  Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

6.  Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; P Chase; S H Polmar
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Cell-mediated immunity in patients with cystic fibrosis.

Authors:  A Gibbons; J D Allan; A Holzel; H McFarlane
Journal:  Br Med J       Date:  1976-01-17

8.  Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.

Authors:  R A Shooter; K A Walker; V R Williams; G M Horgan; M T Parker; E H Asheshov; J F Bullimore
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

9.  Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.

Authors:  R G Doggett; G M Harrison
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

10.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

View more
  15 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.

Authors:  S Worgall; T Kikuchi; R Singh; K Martushova; L Lande; R G Crystal
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.

Authors:  Stefan Worgall; Anja Krause; Michael Rivara; Kyung-Kim Hee; Enrico V Vintayen; Neil R Hackett; Peter W Roelvink; Joseph T Bruder; Thomas J Wickham; Imre Kovesdi; Ronald G Crystal
Journal:  J Clin Invest       Date:  2005-04-01       Impact factor: 14.808

5.  Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

Authors:  Anja Krause; Wen Zhu Whu; Yaqin Xu; Ju Joh; Ronald G Crystal; Stefan Worgall
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

6.  IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.

Authors:  Patricia J Dubin; Jay K Kolls
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-27       Impact factor: 5.464

7.  Pseudomonas aeruginosa: mannose sensitive hemagglutinin inhibits the growth of human hepatocarcinoma cells via mannose-mediated apoptosis.

Authors:  Zhenyuan Cao; Lijun Shi; Ying Li; Jinghua Wang; Dandan Wang; Guangyou Wang; Bo Sun; Lili Mu; Mingfei Yang; Hulun Li
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

8.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa.

Authors:  M M Stevenson; T K Kondratieva; A S Apt; M F Tam; E Skamene
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

10.  Suppression of lymphocyte proliferation by Pseudomonas aeruginosa: mediation by Pseudomonas-activated suppressor monocytes.

Authors:  T B Issekutz; J M Stoltz
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.